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  SHOCK INDEX AS PREDICTOR OF OUTCOME IN PATIENTS WITH SEPSIS 
                                                     A COHORT STUDY   
INTRODUCTION 
Sepsis has been described in humans since 700 BCE. The Greeks used the term  Σήψις 
(sepsis), referring to rot or decomposition. It referred to a condition associated with 
infection, which is life-threatening and has high risk of death.  
Even in the modern era with availability of sophisticated modalities for organ support in 
critical care units, sepsis remains as a syndrome which is difficult to define and diagnose, 
resulting in high morbidity and mortality. The importance of early recognition of sepsis 
with initiation of treatment and its effects on survival outcome have long been 
recognized. Due to this non- availability of easy diagnostic scores and criteria, multiple 
attempts are being made to develop scores which can identify sepsis early. 
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  AIM 
To study the disease spectrum of patients with suspected sepsis and assess the usefulness 
of shock index in predicting the clinical outcome. 
 OBJECTIVES 
PRIMARY OBJECTIVE: 
To assess whether in patients with suspected sepsis, shock index is a good predictor of 
clinical outcome. 
           
SECONDARY OBJECTIVES: 
Role of shock index in predicting ICU requirement. 
Shock index in predicting hemodynamic support. 
Shock index in predicting ventilatory requirement. 
Shock index and its relation to duration of hospital stay. 
Correlation of shock index with other mortality predictors (lactate levels, initial SOFA 
score and q SOFA score). 
Usefullness of shock index across the various etiologies for sepsis. 
17 
 
 
                                                   REVIEW OF LITERATURE 
DEFINITIONS 
SEPSIS: 
      Sepsis is as a systemic response to infection , which is manifested by two or more of 
the following -   
Temperature >38 or <36 
Heart rate >90 beats per minute. 
Respiratory rate >20 breaths per minute or PaCO2 <32 mm Hg 
WBc count >12,000/cumm, <4000/cumm, or >10% immature forms. 
SEVERE SEPSIS: 
      Severe sepsis is defined as sepsis that is associated with evidence of organ 
dysfunction, hypoperfusion, or hypotension.  The hypoperfusion abnormalities may 
include, but are not limited to oliguria, lactic acidosis or an acute change in mental status.  
SEPSIS INDUCED HYPOTENSION: 
 Sepsis induced hypotension is defined as a systolic blood pressure <90 mmHg or a 
reduction of >40 mmHg from baseline, in the absence of other causes of hypotension. 
18 
 
 
 
SEPTIC SHOCK  
Septic shock is defined  sepsis induced hypotension, which persists despite adequate fluid 
resuscitation along with perfusion abnormalities that may include, but are not limited to 
lactic acidosis, oliguria or an acute change in mental status. Patients receiving inotropic 
or  vasopressor agents may not be hypotensive at the time when perfusion abnormalities 
are measured. 
 
 
                                        Figure 1: Natural history of sepsis. 
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GLOBAL SCENARIO 
Up to 46% of the hospitalized septic patients are admitted through hospital emergency 
departments(1). However, the initial evaluation of patients with suspected infection in the 
emergency department is complicated by : 
1) heterogenecity of  presentation , including clinical signs and symptoms, site of  
infection, etiologic micro-organisms and underlying co-morbid conditions. 
 2) the challenge in rapidly identifying the patients  who are most likely to progress to 
severe illness or death, especially among patients who are not severely ill at the time of 
initial evaluation. 
Approximately one of every four patients with confirmed infection who presents to the 
emergency department with an uncomplicated sepsis progresses to severe sepsis or septic 
shock within 72 hours and the early progression to septic shock is associated with higher 
30-day mortality (2). 
Severe sepsis accounts for about 2% of all hospital admissions and  these patients 
comprise an estimated  17% of in-hospital deaths(3). Severe sepsis is a leading cause of 
death in the United States and the most common cause of death among critically ill 
patients in non-coronary intensive care units (ICU) (4). In the United States, the 
incidence of severe sepsis is estimated to be 300 cases per 100 000 population(1). 
Approximately half of the deaths due to sepsis occur outside the ICU. A fourth of patients 
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who develop severe sepsis will die during their hospitalization. Septic shock is associated 
with the highest mortality, approaching 50%. 
 
 
                     Figure 2: Epidemiology of sepsis in United states (5). 
 
Over the past decade, annual hospitalizations for septicemia or sepsis have more than 
doubled, without a corresponding increase in overall hospitalizations due  to other causes 
during  that time period (6). 
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 This trend is expected to continue due to aging of the population, increasing burden of 
chronic health conditions, and increased use of immunosuppressive therapy, 
chemotherapy, transplantation and other invasive procedures. Over the past 2 decades, 
the case-fatality has declined due to advances in supportive care for the critically ill(6)
 
 
Recent data suggest the annual cost of hospital care for patients with septicemia is $14 
billion in United States. Therefore, sepsis and severe sepsis are important public health 
problems. 
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INDIAN SCENARIO 
Sepsis is a leading cause of admission into the Indian Intensive Treatment Units (ITUs) 
and is a major cause of mortality(7). However, awareness about sepsis in India is quite 
low , both among health care professionals and patients (8). 
The respiratory tract and urinary tract are the predominant source of sepsis (9). 
 
 
 
SITE OF SEPSIS 
 
NUMBER OF PATIENTS 
 
PERCENTAGE 
URINARY TRACT 122 30.5 
RESPIRATORY TRACT 85 21.25 
SKIN 56 14 
INTRAABDOMINAL 52 13 
MENINGITIS 38 9.5 
UNKNOWN SITE 47 11.75 
TOTAL 400 100 
 
                      Table 1: Source of sepsis in India (10) 
Gram negative infections are the most common cause for sepsis, and   enterobacteriaceae  
account for majority of these infections. Most common is E. coli , followed by klebsiella 
and pseudomonas(11). Off the Gram positive infections staphylococcus is the most 
common. Among  the acute undifferentiated febrile illnesses,  Scrub typhus is the most 
common (35.9%),  followed by dengue (30.6%), malaria (10.4%), enteric fever (3.7%) 
and leptospirosis (0.6%) (12). 
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Table 2: Microbiological profile of sepsis (13). 
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RISK FACTORS FOR POOR OUTCOME 
Age, male gender, black race, and increased burden of chronic health conditions are 
important risk factors which determine outcome in patients with sepsis(14). The 
incidence of severe sepsis increases disproportionately in older adults, and more than half 
of severe sepsis cases occur in adults over 65 years of age(15). 
Life style associated chronic diseases: More than half of patients who develop severe 
sepsis also have at least one chronic health condition (eg: diabetes). Infection remains an 
important cause of morbidity and mortality in diabetics, probably due to abnormalities of 
the host response, particularly in neutrophil chemotaxis, adhesion and intracellular 
killing(16). 
Immunodeficiency and sepsis: Sepsis and Human Immunodeficiency Virus (HIV) is also 
an area of concern. The epidemiology of sepsis in patients with HIV has changed 
significantly with advancements in highly active antiretroviral therapy (HAART) and 
Pneumocystis jirovecii prophylaxis. Over the past decade, the proportion of HIV-positive 
patients admitted to the ICU has increased, as well as their overall survival. Compared 
with the pre-HAART era, currently  most HIV-positive patients who are hospitalized or 
admitted to the intensive care unit,  die of non-AIDS-related illness, the most common 
being sepsis (17). 
Causative organisms virulence and sepsis outcome: The type of organism causing severe 
sepsis is an important determinant of outcome. Although most recent studies have 
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suggested an increasing incidence of gram-positive organisms, the latest European 
Prevalence of Infection in Intensive Care (EPIC II) study reported more gram-negative 
organisms (62.2% vs. 46.8%) (18). The rate of gram negative bacteremia was 
significantly higher in patients with septic shock than in patients with severe sepsis or 
with sepsis (43.0% vs. 22.7% vs. 22%, respectively). Patients with severe sepsis also had 
higher rates of mixed bacteremia than patients with severe sepsis or with sepsis (12.3% 
vs. 5.3% vs. 3.1%, respectively). By contrast, the rate of gram-positive bacteremia was 
greater in patients with sepsis and with severe sepsis than in those with septic shock 
(72.4% vs. 68% vs. 43.9%, respectively) (19). 
IMPORTANCE OF EARLY RECOGNITION OF SEPSIS 
 In the early stages of sepsis, the inflammatory system becomes hyperactive (both 
humoral and cellular defense mechanisms). However, as the disease progresses, this 
hyper-inflammatory state is coverted to the anti-inflammatory state, which is marked by 
decreased levels of TNF and increased levels of IL-10.  Increased production of IL-10 in 
the late phase of sepsis contributes to immunosuppression. Depletion of immune cells 
including lymphocytes compromises the immune system’s ability to control infection, 
thereby contributing to increased morbidity in sepsis (20). 
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                               Figure 3: Inflammatory response to sepsis. 
 
If sepsis is identified early and aggressively treated, then mortality benefits are highest. 
There is evidence suggesting less hospital mortality in  patients assigned to early goal 
directed therapy . Early identification results in early therapeutic intervention to restore 
balance between oxygen delivery and oxygen demand (21). Delay in recognition of  those 
who are in sepsis  causes ongoing volume depletion and microcirculatory inflammation,  
resulting in severe and irreversible organ dysfunction (22). 
The initial golden hours during which transition to serious illness occurs may elapse in 
emergency department or in the hospital wards.  
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NEED FOR SCORING SYSTEMS FOR TRIAGING SEPTIC PATIENTS 
Sepsis is a life threatening condition which needs timely recognition and appropriate 
treatment. However no rapid diagnostic tests are currently available to accurately identify 
the patients with sepsis or those at high risk of developing sepsis. This is unlike certain 
other life-threatening conditions (eg: myocardial infarction), for which highly accurate 
diagnostic tests are available. Moreover, diagnostic tests for sepsis like culture will take 
atleast 48  hours to become positive and that delay in antibiotics while waiting for a 
culture wil be associated with poorer outcomes.  Thus in the meantime, clinicians must 
rely on their clinical judgement  to identify sepsis among patients with infection. 
Multiple attempts  have been made to develop an empirically derived score using simple 
clinical criteria, to potentially assist bedside clinicians in identifying those patients with 
sepsis or those likely to develop it. 
Some of the commonly used outcome predictors are: 
SOFA score 
q SOFA score 
Lactate level 
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. SOFA SCORE 
The sequential organ failure assessment (SOFA) score was developed to describe the 
time course of multiple organ dysfunctions using a limited number of routinely measured 
variables. The functions of six organ systems are scored from 0 (no organ dysfunction) to 
4 (severe organ dysfunction). The individual organ scores are then summed to a total 
score between 0 and 24 (23). 
 
                      Table 3 : The SOFA scoring system 
SOFA scores can be calculated at various times, during the course of hospitalization, and 
are named accordingly ( eg: Initial SOFA, highest SOFA etc). The initial, highest, and 
mean SOFA scores all correlates well with mortality. Initial SOFA and highest SOFA 
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scores of more than 11 or mean scores of more than 5 corresponded to mortality of more 
than 80%. The mean and highest SOFA scores have the strongest correlation with 
mortality, followed by Δ-SOFA and initial SOFA scores. Except for initial scores of more 
than 11 (in which case mortality rate is  >90%), a decreasing score during the first 48 
hours was associated with  decreasing mortality rates (24).  
 
                      Figure 4: SOFA score and mortality (25) 
 
The baseline SOFA score should be assumed to be zero unless the patient is known to 
have a preexisting (acute or chronic) organ dysfunction before the onset of infection. 
Depending on  patient’s baseline level of risk, a SOFA score of 2 or greater identified a 
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2- to 25-fold increased risk of dying  when compared with patients with a SOFA score 
less than 2 (26). 
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qSOFA SCORE 
The quick SOFA (qSOFA) score came to prominence in 2016, after an international task 
force redefined the clinical criteria for sepsis, resulting in the development of  the Third 
International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). q SOFA is  a 
surrogate for SOFA in those settings in which all components of SOFA are not routinely 
measured. 
It has 3 components: 
Respiratory rate >21 breaths/min 
Systolic arterial blood pressure ≤100 mm Hg 
Altered mental status (Glasgow Coma Scale <15). 
q SOFA appears a simple, rapid, inexpensive, and valid way to identify sepsis among 
patients with suspected infection (27). qSOFA is a better predictor for in-hospital 
mortality than were SIRS or SOFA in a non-ICU setting (26). The utility of qSOFA will 
likely become surpassed when highly accurate, rapid diagnostic tests for sepsis emerge.  
However, till then  it can  be used for risk stratification and consideration for sepsis in 
emergency department (ED) patients with suspected or confirmed infection(28). Patients 
with a qSOFA score of 2 or higher had an in-hospital mortality rate of 24% compared 
with 3% for patients with a qSOFA score of less than 2 (29). 
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LACTATE LEVEL 
Lactate is an important source of energy, especially during starvation. Therefore, humans 
cannot survive when lactate is not produced.  Lactate is converted to lactic acid and this 
contributes to acidic environment. Lactate can also be converted to bicarbonate and 
becomes a main source of alkalemia under normal physiological conditions.  
Normal daily production of lactate is 1,400–1,500 mmol/L per day . It is formed from the 
reduction of pyruvate, which inturn is  generated largely by anaerobic glycolysis. 
Clearance of lactate  typically occurs in the liver (60%),  kidney (30%) and to a lesser 
extent by other organs (cardiac and skeletal muscle). In Patients with sepsis increased 
serum lactate level is thought to be due (30): 
Tissue hypoxia leading to increased anaerobic glycolysis resulting in overproduction of 
lactate.  
Decreased lactate clearance as a result of liver dysfunction and acute kidney injury. 
Lactate clearance usually cannot overcome lactate production and this may be worsened 
during critically ill status.  
Multiple studies have found that acute hospital mortality was significantly higher in 
patients with higher serum lactate level than those with lower serum lactate level. Thus 
lactate level has  been used as a prognostic indicator for mortality.  In particular, those 
patients with an initial serum lactate level greater than or equal to 4.0 mmol/L had higher 
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mortality risks, and the probability of death was substantially increased with a high initial 
lactate level. 
Lactate level greater than or equal to 4.0 mmol/L was 36% (95% confidence interval [CI] 
27% to 45%) sensitive and 92% (95% CI 90% to 93%) specific for any death; it was 55% 
(95% CI 41% to 68%) sensitive and 91% (95% CI 90% to 93%) specific for acute death 
(that is, death within 3 days) (22).  
Acute-phase deaths and in-hospital deaths increased linearly with lactate levels. An initial 
lactate ≥ 4.0 mmol/l was associated with sixfold higher odds of acute-phase death; 
however, a lactate level less than 4 mmol/l had little impact on probability of death(30). 
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SHOCK INDEX 
Shock index (SI) is defined as heart rate divided by systolic blood pressure. The normal 
range  is from  0.5 to 0.7 in healthy adults.  
Shock index is a  simple bedside tool which can be used even by non-medical personnel 
(31). 
 
 
 
 
In patients with sepsis, peripheral vasodilatation results in decrease in systemic vascular 
resistence (SVR). Heart rate increases as a compensatory mechanism, in an attempt to 
maintain the blood pressure. Thus in the early stages of sepsis, the blood pressure may be 
normal. Hence blood pressure alone maynot  be a reliable marker in identifying patients 
with early sepsis. However shock index would be increased, owing to the tachycardia, 
and thus can predict early sepsis. 
BACKGROUND 
The concept of shock index was initially introduced in 1967 by Allgöwer and Buri  as a 
method for assessing  the degree of hypovolemia in hemorrhagic and infectious shock 
35 
 
states (31). SI is linearly inversely related to physiologic parameters, such as cardiac 
index, stroke volume, left ventricular stroke work, and mean arterial pressure (32).  
SI may be a valuable tool for the early recognition and evaluation of critical illness in the 
ED. SI ≥ 0.9 predicted higher illness priority at triage, higher hospital admission rates, as 
well as intensive therapy on admission than pulse or blood pressure alone (33). SI ≥ 1.0 
has been associated with significantly poorer outcomes in patients with acute circulatory 
failure(32).  It can also be used as a means to track progress of resuscitation(34). SI 
indicate persistent failure of left ventricular function during aggressive therapy of shock 
patients in the emergency department(34). 
In a pilot study, shock index was used to predict 28 day mortality in adult patients above 
21 years of age, with severe sepsis and admitted for a suspected or confirmed infection. It 
was found that Shock index performed well as a predictor of hyperlactatemia and 28-day 
mortality . Subjects with a shock index of 1.0 or greater  were 3 times more likely to have 
hyper-lactatemia and the mortality rates were also 3 times greater than those with a shock 
index of less than 1.0 (35). Gandhi et al suggested that higher the shock index at 
presentation, higher is the mortality (36). 
The predictive accuracy of shock index for death at a cut-off point of ≥ 1.0 has a 
sensitivity of 80.8% and a specificity of 79.2% (37). 
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JUSTIFICATION FOR STUDY 
A cost effective, easily attainable parameter would greatly assist in the effective 
management of sepsis patients, especially in emergency departments that are sub-
optimally equipped ( Peripheral / sub-urban hospitals). Many emergency departments in 
the peripherals / districts are not readily equipped with laboratory equipments and arterial 
blood gas machines due to their high cost, thus making lactate calculation and assessment 
of SOFA scores impossible. This compromises the accurate risk stratification of sepsis 
patients and delays the management. Shock index thus can act as a good triage tool in 
these settings. Even though there are data from western literature about shock index in 
sepsis patients, Indian data are sparse.  
This study thus aims to study the usefulness of shock index in patients with sepsis as a 
predictor of outcome. 
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                                                     METHODOLOGY 
STUDY SETTING 
This study was conducted in the period between 1
st
 January 2016 to 30
th
 June 2017 , in 
Christian Medical College, Vellore. During this period of 18 months, all patients with 
suspected infection and 2 or more SIRS criteria , who were admitted in the department of 
internal medicine (both medical wards and medical intensive care units) through the adult 
emergency department,  fulfilling the inclusion criteria were included in the study.  
STUDY DESIGN 
This is a cohort study done on patients with suspected infection who were admitted in the  
medical wards and medical Intensive Care Units (MICU).  The disease spectrum and the 
outcomes were studied. Shock index at initial presentation to the emergency medicine 
department (ED) was compared to the traditional mortality predictors like serum lactate 
and SOFA score , and the newly designed q SOFA score. 
 PARTICIPANTS 
Inclusion criteria: 
Adults more than 18 years. 
Suspected infection with fulfillment of two of the four criteria for systemic inflammatory 
response syndrome. 
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Exclusion criteria: 
Age less than 18 years 
Presence of acute cerebrovascular event 
Acute coronary syndrome 
Acute pulmonary edema 
Status asthmaticus 
Cardiac dysrhythmias (as primary diagnosis) 
Contraindication to central venous catheterization 
Acute gastrointestinal haemorrhage 
Seizure 
Drug overdose 
Burn injury 
Trauma 
Requirement for immediate surgery 
Uncured cancer (during chemotherapy)  
Immunosuppression (because of organ transplantation) 
39 
 
Do not resuscitate status 
 
        All the patients meeting the required criteria were enrolled into the study thus 
minimizing the chances of any selection bias. 
 SAMPLE SIZE CALCULATION 
 
Single Proportion - Absolute Precision 
Expected  Proportion 
 
0.24 
Precision (%) 5 
Desired confidence level  (1- alpha) % 95 
Required sample size 280 
  
With reference to Tony etal, Western Journal of emergency medicine march 2013. The 
proportion of patients with severe sepsis with a Shock Index of >=1 was found to be 24% 
with a precision at 5% and a desired confidence interval at 95% we needed to study at 
least 280 patients with severe sepsis. 
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FUNDING AND APPROVAL 
Funding source 
A FLUID Research grant (Institutional grant) was approved for the purpose of this study 
after the institutional review board and ethics approval 
The research proposal was discussed with the Institutional Review Board in April 2017 
and approval was obtained [IRB Min. No 10635 dated 03 .04.2017]. 
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There were no ethical issues related to this study. Institutional review board approval was 
obtained prior to the commencement of the study. 
 
RECRUITMENT AND DATA COLLECTION 
As this was a retrospective study , all patients with suspected sepsis who fulfilled the 
inclusion criteria, and were admitted under the department of internal medicine, CMC 
Vellore were included.   
Their initial vital signs, as recorded by the triage staff nurse of the Emergency department 
were used for calculating the shock index and q SOFA scores. 
          Initial blood investigation reports which were sent from the ED including 
haemoglobin, WBC counts, platelet counts, blood lactate levels, serum creatinine,  
bilirubin,  P/F ratio, Sodium , potassium,  were noted and were used for calculating the 
initial SOFA score and further analysis. The results of blood cultures and serology reports 
were also obtained from the hospital records. 
All the collected data were entered into  the IRB approved study performa 
simultaneously. 
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DETAILED ALGORITHM OF THE STUDY 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients with suspected infection presenting to the ED. 
Patients with 2 or more SIRS features who fulfill the 
inclusion criteria 
Entry made into the data collection form  
Initial Shock index , SOFA and q SOFA scores 
calculated 
Outcome assessed as condition at discharge ( alive / 
died/ DAMA) 
Figure 5: Algorithmic representation of the study 
plan 
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PRIMARY AND SECONDARY OUTCOMES 
PRIMARY OUTCOME 
The pimary outcome studied was the clinical condition at discharge. 
SECONDARY OUTCOME 
Number of patients needing ICU admission within the initial 48 hours. 
Need for hemodynamic support within the initial 48 hours. 
Need for  ventilatory support ( non-invasive / invasive) within initial 48 hours. 
Duration of hospital stay. 
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 DATA ANALYSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients admitted in medical wards / 
ICU.    Total 590 patients recruited 
 
 15  patients with 
DNI / DNR status 
 
 
15 patients were excluded 
 
Totally 575 patients included 
 
ED vital signs  & laboratory values were noted. 
 
Initial Shock index , SOFA scores and q SOFA scores calculated. 
 
Primary outcome 
(alive / died / 
DAMA) assessed 
 
Secondary 
outcomes 
assessed 
 
Figure 6 : Strobe statement 
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STATISTICAL ANALYSIS:  
    Data entry was done using EPI data and data analysis done using SPSS.16.0 . 
Descriptive statistics were reported using Mean+/- SD for continuous variables and 
Frequency and percentage for categorical variables. Association between the variables 
towards were done using Chisquare /Fisher’s exact test for categorical variables, two 
independent sample t test for continuous variables after checking for normality. Risk 
factor analysis for the cause of Mortality were done using Binary logistics regression 
using step wise method, Odds ratio and 95% confidence interval were reported. P value 
<0.05 was considered as statistically significant. 
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                                                                       RESULTS 
 
BASELINE CHARACTERISTCS 
TOTAL (n=575) 
BASELINE     NUMBER ( % ) 
Age (years)     51.62 +/- 15.9                                                                                                                              
Males      278  (48.30) 
Diabetics 
Poorly controlled (HbA1c >8gm%)  
     199  (34.60) 
     110   (19.10) 
HIV positive      11  (1.90) 
SIRS SCORE 
2 
3 
4 
 
     227( 39.50) 
     308(53.50) 
     40  ( 7.00) 
Confirmed infection (culture/ X ray/ 
serology) 
Culture positive 
X ray positive 
Serology / PCR positive 
     451(78.40) 
     217 (37.70) 
     66( 11.40) 
     168  (29.21) 
LACTATE >= 4 (n=481)      118  (24.50) 
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q SOFA  >= 2      341  (59.30) 
SOFA >=11 ( n=481)      90   (18.70) 
Shock Index  
Less than 0.7 
0.7 to 1.0 
More than or equal to 1.0 
 
     10  (1.70) 
    159  (27.70) 
    406  (70.40) 
                          
                              Table 4: Baseline characterisctics 
 
Table 4 shows the baseline characteristics of the study population. 
AGE AND GENDER : Mean age of the patients were 51.6  ± 15.9 years. 48.3 % (278) 
were males.  
DIABETES :  199 (34.6 %) patients were diabetics. 110 (19.1 %) had poorly controlled 
diabetes, with HbA1c values greater than 8.0gm %. 
HIV STATUS : 11 (1.9 %) of the study population were seropositive for HIV. 
SIRS SCORE: Only patients with SIRS score 2 and above were included in this study.             
227 (39.5 %) patients had SIRS score of 2 at the time of presentation to the emergency 
department. The number of patients with SIRS score of 3 and 4 were 308 (53.5 %) and 40 
(7.0%) respectively. 
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INFECTION : Among the 575 patients, 451 (78.4 %) had a confirmed infection ( culture 
/ X ray positive / serology positive). 217 (37.7 %) had positive culture reports. Chest X 
ray was suggestive of pneumonia in 66 (11.4 %) and 168 (29.2 %) had positive serology 
results. 
 
                                   Figure 7: Culture positive sepsis 
 
SERUM LACTATE: 481 out of the 575 patients had serum lactate values measured at 
the initial contact in the emergency department. Among these 481 patients, 118 (24.5 %) 
patients had lactate levels more than or equal to 4.0mmol/L. 
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SOFA SCORE: Similar to the lactate levels, complete SOFA scores were available for 
481 patients, and of these 90 (18.7 %) had initial SOFA score of more than 11. 
q SOFA SCORE: Of the 575 patients, 341 (59.3 %) had q SOFA score greater than or 
equal to 2. 
SHOCK INDEX: Initial shock index was less than 0.7 in 10 (1.7 %) patients.  159 
(27.7%) had shock index between 0.7 to 1.0 and 406 (70.6 %) had shock index values 
greater than 1.0 at presentation. 
 
SOURCE OF SEPSIS (CULTURE + X RAY POSITIVE) 
 N= 283  
Lungs 
 
91 32.15 
Urine 
 
142 50.17 
Bacteremia without 
identifiable source 
44 15.54 
Others 
 
6 2.14 
 
                          Table 5: Source of sepsis 
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Table 5  denotes the source of sepsis in culture and X ray positive cases. Lungs accounted 
for 32.15 % of cases and urinary source contributed 50.17% cases. 
 
 
ETIOLOGY OF CULTURE POSITIVE SEPSIS 
CULTURE POSITIVE   NUMBER   (%) 
E . coli     106  (48.80) 
Klebsiella     19  (8.80) 
Pseudomonas     13  (6.00) 
MRSA     8  (3.70) 
MSSA     9  (4.10) 
Streptococcus pneumonia     15  (6.90) 
Salmonella typhi     7  (3.20) 
Others     40  (18.40) 
TOTAL     217 
 
            Table 6: Etiology of culture positive sepsis 
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A positive culture result was obtained in 217 (37.7 %)  patients . Among the culture 
positive group, E coli was the most common etiological agent accounting for 48.8% of 
cases. Klebsiella caused 19 (8.8 %) infections and pseudomonas was responsible for 13 
(6.0 %) infections. Number of culture positive cases caused by MRSA was 8 (3.70 %) 
and MSSA was responsible for 9 (4.1 %) admissions. Streptococcus pneumonia and 
Salmonella typhi were responsible for 15 (6.9 %) and 7 (3.2 %)  cases respectively. 
 
SEROLOGY /PCR POSITIVE SEPSIS 
 
INFECTIOUS AGENT 
 
    NUMBER  ( %) 
Scrub typhus     93   (55.30) 
H1N1  influenza     42  (25.00) 
Malaria     21  (12.50) 
Dengue     10   (5.95) 
Leptospirosis     2   (1.20) 
TOTAL     168 
                     Table 7: Etiology of serology / PCR positive cases 
Table 7 denotes the number of patients with positive serological studies. 
Serological studies and Polymerase chain reaction identified the offending agent in 168 ( 
29.2 %) patients. Among this group scrub typhus ELISA was positive in 55.3 % (93 
cases), dengue serology was positive in 5.95 % ( 10 cases), H1N1 PCR was positive in 
52 
 
25.0% (42 cases) and malarial smears were positive in 12.5 % (21 cases).  2 patients were 
tested positive for leptospiral infection. 
 
 
 
CLINICAL CHARACTERISTICS                                                                                                               
                                                                                                                                           n = 575 
Altered mental status (GCS <15)                                                                              137  (23.8) 
Abnormal temperature 
Hypothermia ( <36 F)                                                                                                 1      (0.20) 
Hyperthermia  (>38 F)                                                                                                82   (14.3) 
Tachypnea ( Respiratory rate >20/min)                                                                      521  (90.6) 
Tachycardia (heart rate >90/min)                                                                               571   (99.3) 
Hypotension ( Systolic BP <=100mmHg)                                                                  321   (55.8) 
                
                                     Table 8: Clinical characteristics 
Table 8 depicts the clinical characteristics of the study population. Altered mental status, 
defined as GCS less than 15 was present in 23.8 % (137 cases). Only 1 patient was found 
to be hypothermic, however 82 (14.3 %) patients had elevated temperature (greater than 
38 degree Fahrenheit). 
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521 (90.6 %) patients had respiratory rate more than 20/min at the time of presentation. 
SIRS criteria for tachycardia ( heart rate > 90 /min) was present in 571 (99.3 %) , and 321 
(55.8 %) patients were hypotensive with systolic blood pressure less than 100mmHg. 
 
 
LABORATORY PARAMETERS 
 
1. SERUM CREATININE 
 
                  Figure 8: Serum creatinine at admission 
Figure 8 denotes the serum creatinine values of patients.  
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Creatinine of less than 1.2mg/dl was present in 311(54.0 %)  patients. 128 (22.7 %)  had 
ceatinine between 1.2 and 1.9, and 69 (12.0 %) patients had values between 2.0 and 3.4. 
The number of patients with serum creatinine between 3.5 – 4.9 and greater than 5mg/dl 
were 40(7.0) and 27 (4.3 %)  respectively. 
 
 
 
2. SERUM TOTAL BILIRUBIN 
 
Figure 9: Total bilirubin values at admission. 
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381(66.2 %)  patients had bilirubin less than 1.2 mg/dl , and 86 (14.9 %) had values 
between 1.2 to 1.9 mg/dl. Bilirubin values between 2.0- 5.9 mg/dl was present in 78 (13.6 
%)  patients and, 20 (3.5%) patients had bilirubin between 6.0-11.9 mg/dl. 10 (1.8 %) 
patients had serum bilirubin levels elevated beyond 12 mg/dl. 
 
3. PLATELET COUNT 
 
                             Figure 10: Platelet counts at admission 
Platelet counts of more than 1.5 lakh was present in 318 (55.3%) patients. 86 (14.9 %) 
patients had platelet between 1.0 – 1.5 lakh and 75 (13.0 %) patients had platelets 
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between 50,000- 1.0 lakh. In 56 (9.7 %) patients, platelet count was between 20,000-  
50,000 and in 40 (8.1 %)  patients platelet count was less than 20,000. 
 
 
4. WBC COUNT 
 
                                    Figure 11: WBC count at admission. 
 Figure 11 denotes the WBC counts at admission. 214 (37.2 %) patients had WBC counts 
between 4000-12,000 cells/cumm. 42 (7.3 %)  patients had WBC counts less than 4000 
and in 319 (55.5 %)  patients the WBC counts were more than 12,000 cells/cumm. 
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5. P/F RATIO 
 
                                          Figure 12: P/F ratios at admission 
Among the 575 patients included, only 481 patients had P/F ratios documented in the 
emergency department. Among this 481 patients, 79 (16.4 %) had P/F ratio greater than 
400, 116 (24.1 %)  had P/F ratio between 300-400, 119 (24.8 %)  had P/F ratio between 
200-300, 102 (21.2 %)  had P/F ratio between 100-200 and 65(13.5 %)  patients had P/F 
ratio less than 100. 
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6. OTHER PARAMETERS 
 VARIABLE MEAN STANDARD 
DEVIATION 
A HEMOGLOBIN (gm/dl) 11.46 2.5 
B SODIUM (meq/L) 130.5 7.1 
C POTASSIUM (meq/L) 3.91 0.8 
 
Table 9: Hemoglobin electrolytes at admission. 
Hemoglobin level was 11.46 ± 2.5 gm %. Sodium level at presentation to the emergency 
department was 130.5  ± 7.1 meq/L and potassium level was 3.91  ± 0.8 meq/L. 
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PRIMARY OUTCOME: 
OUTCOME AT DISCHARGE 
The primary outcome studied was the clinical condition at discharge. 
 
                                     Figure 13: Condition at discharge 
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Among the 575 patients included in the study, 395 (68.7 %) improved and were 
discharged. 166 (28.8 %) patients died during the hospital stay and 14 (2.5 %)  patients 
were discharged against medical advice. 
 
 
SHOCK INDEX AND OUTCOME 
 
 
                              Figure 14: Shock index and condition at discharge 
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In the group with shock index less than 0.7, 6 (60 %)  patients improved and 2 (20 %) 
patients  died. Among the group with shock index between 0.7 and 1.0 , the mortality was  
6.91%.  In the group with shock index of more than 1 at presentation, 242  (59.60 %) 
patients  improved and 153  (37.68 %) died.    
 
 
SECONDARY OUTCOMES 
ICU REQUIREMENT WITHIN INITIAL 48 HOURS OF ADMISSION 
 
            Figure 15: ICU requirement within 48 hours 
Figure 15 represents the ICU requirement within the initial 48 hours of admission. 
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Among the total cohort of patients, 346 (60.1 %)  patients required ward care alone. 213 
(37.0%) patients required admission to the intensive care unit either directly or within the 
initial 48 hours. 16 (2.9 %) patients needed ICU treatment later during the hospital stay, 
that is , 48 hours after admission. 
 
 
 
SHOCK INDEX AND ICU REQUIREMENT 
 
ADMISSION WARD   SHOCK INDEX <1.0 
 
SHOCK INDEX >1.0 
Ward care alone 
 
 
148 198 
 ICU requirement within 
48 hours 
 
20 193 
ICU requirement after 
initial 48 hours 
 
5 11 
 173 402 
 
                Table 10: Shock index and ICU requirement. 
In the shock index less than 1.0 group, only 20 (11.6 %)  required ICU care within 48 
hours, and majority were treated in the ward alone. In the higher shock index group, 193 
(48.0 %) required ICU within the initial 48 hours and 198 (49.2 %) required only ward 
care. 
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INOTROPIC REQUIREMENT WITHIN INITIAL 48 HOURS 
 
                  Figure 16: Inotropic support. 
Figure 16 represents the number of study patients who required inotropes during the 
initial 48 hours. Among the total cohort of patients, 363 required inotropic support within 
48 hours of hospital admission. 
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SHOCK INDEX AND INOTROPIC REQUIREMENT 
 
 NO INOTROPIC SUPPORT NEEDED INOTROPIC 
SUPPORT 
SHOCK INDEX <0.7 
 
10 0 
SHOCK INDEX 0.7-1.0 
 
156 3 
SHOCK INDEX >1.0 
 
197 209 
 
            Table 11: Shock index and inotropic support. 
Table 11 denotes the relation between shock index and need for inotropic support.  
In the cohort with shock index less than 0.7, no one required inotropic support within the 
initial 48 hours. In the group with shock index between 0.7 – 1.0, 3 (1.88 %) people out 
of 159 needed inotropes. In the group with shock index more than 1.0 at admission 209 
(51.4 %) patients needed inotropes in the initial 48 hours. 
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VENTILATORY SUPPORT DURING THE INITIAL 48 HOURS 
 
 
 
     Figure 17: Ventilatory support required by the patients in the initial 48 hours. 
305 (53.0 %) patients did not require any form of ventilator assistance . 113 (19.7 %)  
patients had to be managed with non invasive ventilation (NIV) and 157 (27.3 %) 
required invasive ventilation. 
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SHOCK INDEX AND VENTILATORY REQUIREMENT 
 
 
                       Figure 18: Shock index and ventilator assistance 
In the group with shock index <0.7, only 1(10.0 %)  patient needed  NIV support and 2 
(20.0 %)  required invasive ventilation. In the cohort with shock index between 0.7- 1.0 , 
20 (12.6 %) required NIV and 10 (6.3 %) required invasive ventilation. In the group with 
shock index more than 1.0, 92 (22.7 %) required NIV support and 145 (35.7 %) required 
invasive ventilatory support. 
 
 
 
67 
 
 
SCORING SYSTEMS IN PREDICTING OUTCOMES 
SHOCK INDEX AND OUTCOMES 
 
 
 SI < 1.0 
N = 169 
SI >= 1.0 
N= 406 
Absolute 
Difference % 
 
 
 
PRIMARY OUTCOME 
 
 
  
     
 
      
  
 In- hospital mortality 13   (7.69) 153 (37.68) 29.99 <0.001 
 
SECONDARY OUTCOMES 
 
   
 
   
  
1 ICU requirement in 48 hours 20(11.83) 193 (47.53) 35.70 <0.001 
2 Inotropic requirement during initial 
48 hours 
3 (1.77) 209 (51.47) 49.70 <0.001 
3 Ventilatory requirement during 
initial 48 hours 
33 (19.52) 237 (58.37) 38.85 <0.001 
4 Duration of hospital stay 7 (5,10) 6 (4,10)  0.006 
 
Table 12: Effect of shock index on outcomes. 
Table 12 summarizes the effect of shock index at presentation on the primary and 
secondary outcomes. 
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In-hospital mortality among the cohort with shock index less than 1.0 was 7.69%, 
compared with 37.68% mortality in the cohort with higher shock index at presentation. 
ICU requirement in the groups with shock index less than 1 and the second group with 
more than 1.0, were 11.83% and 47.83% respectively. 
1.77% patients in the group with shock index less than 1, and 51.47 patients in the group 
with shock index more than 1 required inotropes within the first 48 hours of hospital 
admission. 
 
Ventilatory support was needed by 19.52% patients with shock index less than 1, 
compared to 58.37% patients requiring the same in the other group. 
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q SOFA AND OUTCOMES 
 
 
 
qSOFA < 2 
    (n= 234 ) 
qSOFA  >= 2 
  (n= 341) 
Absolute  
difference  % 
 
p VALUE 
 
 
PRIMARY OUTCOME 
 
  
 
   
1  In- hospital mortality  25 (10.68) 141  (41.34) 30.66 <0.001 
 
SECONDARY OUTCOMES 
 
    
1 ICU requirement in 48 hours 36 (15.38) 177 (51.90) 36.52 <0.001 
2 Inotropic requirement during initial 
48 hours 
15 (6.41) 197 (57.77) 51.36 <0.001 
3 Ventilatory requirement during 
initial 48 hours 
63 (26.92) 207 (60.70) 33.78 <0.001 
4 Duration of hospital stay 7 (5,10) 6 (4,9)  0.003 
 
Table 13: q SOFA and outcomes. 
In-hospital mortality in cohort with q SOFA less than 2 was 10.68%, while in the cohort 
with q SOFA score greater than or equal to 2 was higher (41.34%). 
15.38% of patients with low q SOFA score and 51.9% patients with higher q SOFA 
scores required ICU admission in the first 48 hours. 
Inotropic requirements in the two groups( q SOFA less than 2 versus q SOFA greater 
than or equal to 2) were 6.41% and 57.77% respectively. 
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Ventilatory support during the initial 48 hours was required by 26.92% patients in the 
cohort with q SOFA less than 2, while 60.70 patients with higher q SOFA score needed 
ventilator assistance. 
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SOFA SCORE AND OUTCOMES 
 
 SOFA  < 11 
 (n= 419 ) 
SOFA  >= 11                 
(n= 62) 
Absolute 
difference % 
 
p VALUE 
 
PRIMARY OUTCOME 
 
  
 
   
1 In- hospital mortality 112 (26.73 ) 51 (82.25) 55.52 <0.001 
 
SECONDARY OUTCOMES 
 
    
2 ICU requirement in 48 hours 157 (37.47) 56 (90.32) 52.85 <0.001 
3 Inotropic requirement during 
initial 48 hours 
151 (36.03) 55 (88.70) 52.67 <0.001 
4 Ventilatory requirement during 
initial 48 hours 
208 (49.64) 59 (95.16) 45.52 <0.001 
5 Duration of hospital stay 7 (5,10) 3.5  (2,9)  <0.001 
 
Table 14: SOFA score and outcomes 
 
Table 14 summarizes relation between SOFA score at presentation and  outcomes. 
As the initial SOFA score more than 11, correlated with poorer outcomes in previous 
studies, the study population was divided  into groups, one group with SOFA score less 
than 11 and the other group with SOFA score greater than or equal to 11. 
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In-hospital mortality was 26.73% among the group with SOFA score less than 11, while 
in thr group with higher SOFA score mortality was 82.25%. 
37.47% of patients with lower SOFA score and 90.32 % of patients with SOFA score 
greater than 11 required ICU admission. 
Inotropic support was required by 36.03% patients with SOFA score less than 11, 
compared to 88.70% patients requiring inotropes in the other group with SOFA score 
greater than or equal to11. 
Ventilatory support in the two groups (SOFA 11 versus SOFA greater than or equal to 
11) were 49.64% and 95.16% respectively. 
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SERUM LACTATE LEVELS AND OUTCOME 
 
 
 
 
Lactate  < 4.0 
    (n= 363 ) 
 
Lactate  >= 4.0 
  (n= 118  ) 
Absolute  
difference % 
 
 
p VALUE 
 
PRIMARY OUTCOME 
 
  
 
  
 
  
1 In- hospital mortality 86  (23.69 )  77 (65.24 ) 41.56 <0.001 
 
SECONDARY OUTCOMES 
    
1 ICU requirement in 48 hours 131(36.08) 82 (69.49) 33.41 <0.001 
2 Inotropic requirement during 
initial 48 hours 
118 (32.50) 88 (74.57) 42.07 <0.001 
3 Ventilatory requirement during 
initial 48 hours 
170 (46.83) 97 (82.20) 35.37 <0.001 
4 Duration of hospital stay 7 (5,10) 5 (2,7)  <0.001. 
 
Table 15: Lactate levels and outcome 
Relation between serum lactate levels and the primary and secondary outcomes are 
summarized in table 15. 
In-hospital mortality was 23.69% in cohort with lactate less than 4mmol/L , compared 
with 65.24% mortality in the cohort with lactate levels greater than or equal to 4mmol/L. 
36.08% patients with lower lactate levels and 69.49% patients with lactate levels greater 
than 4 required ICU admission. 
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Inotropes to maintain adequate mean arterial blood pressure was required by 32.50% 
patients with lactate levels less than 4, while 74.57% patients in the group with higher 
lactate levels needed inotropes. 
Ventilatory support was needed by 46.83% patients with lower lactate levels (less than 
4), whereas, 82.20 patients with lactate levels greater than or equal to 4 needed ventilator 
assistance. 
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CHARACTERISTICS SURVIVORS 
    (n= 395) 
NON SURVIVORS 
     (n= 166) 
p VALUE 
GENDER , Number (%) 
  Male 
  Female 
 
 
 
170 (43) 
225(57) 
 
100 (60) 
66  (40) 
 
 
 <0.001 
Diabetes 
 No 
Good control 
Poor control 
 
236 (60) 
65 (16) 
94 (24) 
 
132 (80) 
19  (11) 
15 (9) 
 
 
 
<0.001 
HIV status 
  Negative 
  Positive 
 
393 (99) 
2 (0.5) 
 
158 (95) 
8 (5) 
 
 
<0.001 
SIRS , Number (%) 
2 
3 
4 
 
166 (42) 
204 (52) 
25 (6) 
 
56 (34) 
96 (58) 
14 (8) 
 
 
 0.16 
q SOFA >= 2  
  No 
  Yes 
 
203 (51) 
192 (49) 
 
25  (15) 
141 (85) 
 
 
<0.001 
SHOCK INDEX >= 1 
  No 
  Yes 
 
153 (39) 
242 (61) 
 
13 (8) 
153 (92) 
 
 
<0.001 
 
  Table 16: Survivor characteristics. 
Diabetic status, q SOFA scores and shock index at presentation affected the overall in-
hospital mortality. 
The number of SIRS features at admission did not have a clinically significant effect on 
the survival. 
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EFFECT OF SHOCK INDEX ON DEATHS DUE TO VARIOUS INFECTIONS 
 ETIOLOGY TOTAL DEATHS SI < 1.0 SI >=1.0 
1 Gram negative bacilli 44 4 40 (90.9%) 
2 Gram positive cocci 14 2 12(85.7%) 
3 Salmonella and others 21 1 20 (95.2%) 
4 Dengue 3 0 3 (100%) 
5 Scrub typhus 10 1 9 (90%) 
6 H1N1 15 2 13 (86.6%) 
 
  Table 17: Shock index as mortality predictor in various infections. 
* Gram negative bacilli – E coli, klebsiella , pseudomonas. 
** Gram positive cocci-  MRSA , MSSA, pneumococcus. 
*** Others- enterococcus, acinetobacter, proteus, NFGNB, burkholderia. 
 
Table 17, represents the relation of shock index on mortality, in infections caused by 
various etiological agents. 
90.9% deaths caused by gram negative bacilli were in the goup with shock index values 
greater than or equal to 1.0. 85.7% of mortality due to gram positive cocci was among 
patients with higher shock index. Similary cohort of patients with high shock index 
greater than 1.0 accounted for 95.2% of deaths caused by salmonella and other 
miscellaneous bacteria. 
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Shock index greater than 1.0 accounted for 100.0% and 90% deaths caused by dengue 
and scrub typhus respectively. Even in H1N1 infections, 86.6% of deaths were in patients 
with high shock index values at admission. 
 
EFFECT OF SHOCK INDEX ON ICU REQUIREMENT 
 
 ETIOLOGY 
 
Needing ICU SI  <1.0 SI > 1.0 
1 Gram negative bacilli 
 
46 4 42 (91.3) 
2 Gram positive cocci 
 
15 2 13 (86.6) 
3 Salmonella and others 
 
18 1 17 (94.5) 
4 Dengue 
 
4 1 3 (75.0) 
5 Scrub 
 
35 3 32 (91.4) 
6 H1N1 
 
23 3 20 (87.0) 
7 Malaria 
 
4 1 3 (75.0) 
 
inf  Table 18: Shock index and ICU admission 
Table 18 summarizes the role of shock index in predicting ICU requirement during the 
initial 48 hours, across the various etiologies. 
Among the gram negative bacilli infections requiring ICU treatment, 91.3% cases had 
shock index greater than 1.0 at presentation, and in infections caused by gram positive 
cocci 86.6% cases requiring ICU had presented with shock index more than 1.0. 
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Similarly shock index greater than 1.0 accounted for 94.5% of ICU admissions caused by 
salmonella and other bacterial infections. In case of dengue and scrub typhus infections 
with ICU admission, proportion of cases with shock index greater than 1.0 were 75.0% 
and 91.4%. Among the H1N1 infections, shock index more than 1.0 predicted 87.0% ICU 
admissions and in case of malarial infections, this was 75.0%. 
 
 
EFFECT OF SHOCK INDEX ON INOTROPIC REQUIREMENT 
 
 ETIOLOGY 
 
Needing 
inotropic 
support 
SI  <1.0 SI > 1.0 
1 Gram negative bacilli 
 
55 1 54 (98.1) 
2 Gram positive cocci 
 
14 0 14 (100.0) 
3 Salmonella and others 
 
21 0  21 (100.0) 
4 Dengue 
 
3 0 3 ( 100.0) 
5 Scrub 
 
27 1 26 (96.2) 
6 H1N1 
 
10 0 10 (100.0) 
7 Malaria 
 
4 0 4 (100.0) 
 
Table 19: Shock index and inotropes in various infections 
Effect of shock index on inotropic requirements among the various etiologies are 
summarized in table 19. 
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98.1% of infections caused by gram negative bacilli requiring inotropes during the initial 
48 hours, had shock index more than 1.0 at presentation in the emergency department. 
Among the infections caused by gram positive cocci, 100% cases requiring inotropes had 
shock index greater than 1.0. Similarly among salmonella and other bacterial infections 
also, all patients needing inotropes had shock index greater than 1.0. Shock index was 
more than 1.0 among 100% of dengue infections and 96.2% of scrub infections , which 
required inotropes. All cases of malaria and H1N1 requiring inotropes had shock index 
above 1.0. 
 
EFFECT OF SHOCK INDEX ON VENTILATORY REQUIREMENT 
 
 ETIOLOGY 
 
Needing 
ventilator 
support 
SI  <1.0 SI > 1.0 
1 Gram negative bacilli 
 
53 4 49  (92.4) 
2 Gram positive cocci 
 
19 4 15 (78.9) 
3 Salmonella and others 
 
23 2 21 (91.3) 
4 Dengue 
 
4 1 3 (75.0) 
5 Scrub 
 
49 9 40 (81.6) 
6 H1N1 
 
29 4 25 (86.2) 
7 Malaria 
 
4 1 3 (75.0) 
 
Table 20: Shock index and ventilator requirements due to various infections. 
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Relation of shock index  to the ventilator support among the various etiological agents are 
summarized in table 20. 
 Shock index was more than 1.0 in 92.4% of  infections caused by gram negative bacilli 
which required ventilator support, and among the gram positive cocci infections which 
needed ventilator support shock index was greater than 1.0 in 78.9% cases. 91.3% cases 
of salmonella infections and infections caused by miscellaneous bacteria requiring 
ventilator support had shock index more than 1.0.  Shock index was more than 1.0 among 
75 % of dengue infections and 81.6%% of scrub infections , which required ventilatory 
support. 75% of malarial infections and 86.2% of H1N1 infections requiring ventilator 
support had shock index values greater than 1.0. 
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                                                DISCUSSION 
BASELINE DEMOGRAPHICS 
Age more than 18 years was an inclusion criteria for enrollment into the study, hence age 
group of the population ranged from 18 years to 95 years. Mean age of the study 
population was 51.6 years, with standard deviation of 15.99 years. There were almost 
equal number of males (48.3%) and females. 
Diabetes as a co-morbidity was identified among 34.6%, and 19.1% of the study 
population had poorly controlled diabetes with HbA1c values greater than 8gm%. The 
prevalence of diabetes in our study group was similar to the population studied by Lee et 
al (38) regarding the predictors of mortality in patients with severe sepsis, who identified 
that 33.9% of the study population had diabetes as a risk factor. 
HIV positive status was identified among 1.9%. 
In our study group majority of patients had an SIRS score of 2 (39.5%) or 3 (53.5%) at 
the time of presentation to the emergency medicine department. 7% of study population 
fulfilled all the 4 SIRS criteria. This SIRS characteristics of the study group were 
comparable to the population studied by Freund et al (29) in which most of the study 
subjects fulfilled either 2 (28.0%) or 3 (33.0%) SIRS criteria. 
Among the study population 78.4% had a confirmed infection. Cultures were positive in 
37.7% of patients and chest X ray was suggestive in 11.6%. Serological testing and PCR 
studies identified another 29.2% etiologies.  In the group with positive culture results 
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(217 patients), 66.3% had bacteremia , 19.4% had positive urine culture results (without 
bacteremia), 11.5% had  sputum culture positive. In 2.8% of the culture positive cases, 
etiological diagnosis was obtained from culture of other body fluids (CSF and pleural 
fluid). 
In our study, urinary tract and lungs were the most common site of sepsis contributing to 
24.7% and 15.8%  respectively of all the cases included in the study and accounting for 
31.5% and 20.2% of patients with confirmed infection. This was in accordance to the 
results from other previous studies. In a study conducted by Anand et al (10) about the 
clinical and microbiological profile of Indian elderly with sepsis, urinary tract infections 
accounted for 30.5% of sepsis and lungs were identified as the source of sepsis in 21.25% 
of cases. Study by Lee et al (38) also concluded that respiratory tract (36.7%) and urinary 
tract are the major source of sepsis. 
In our study E.coli, Pseudomonas and Klebsiella were the major gram negative bacterial 
infections identified and it contributed to 24.0% of all cases. Gram positive infections 
were less common than their gram negative counterparts, and the major gram positive 
pathogens (MRSA, MSSA and pneumococcus) were identified as the cause of sepsis in 
only 5.6% of all admissions. 8.2% infections were caused by salmonella and other 
miscellaneous gram positive and gram negative bacteria. Scrub typhus and H1N1 
accounted for 16.1% and 7.3% respectively of all admissions. Other miscellaneous 
infections identified were malaria (3.7%), dengue (1.7%) and leptospirosis(0.4%). These 
findings from the present study were also comparable to the results from the previous 
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studies. Study done by Sahoo et al (11) regarding the bacteriological profile of culture 
positive septic patients, gram negative infections were identified as the major cause of 
sepsis with enterobactereciae responsible for majority of the cases.This study by Sahoo et 
al also concluded that E.coli followed by Klebsiella and pseudomonas were the major 
gram negative pathogens and that Staphylococcus is the major gram positive pathogen, 
the findings which were comparable to the results obtained from our current study. 
Similar microbiological profile of septic patients were also obtained in a study done by 
Chatterjee et al (39) in which gram negative infections accounted for 73.4% cases, 
followed by gram positive infections (12.6%), fungal infections (6.2%) and other tropical 
infections (7.2%). However, a significant difference was that there were no fungal 
infections identified in our current study. Also, our study finding that scrub typhus 
accounted for a large number of admissions was similar to the results described by 
Abhilash et al (12) and Chatterjee et al. 
 
In our study group, all patients had calculable shock index values and majority of the 
study population (70.6%) had shock index values greater than equal to 1.0 at the time of 
presentation to the emergency department. Similarly q SOFA scores were also available 
for all the patients, with 59.3% of study population having q SOFA score greater than or 
equal to 2. However lactate levels and more complex scoring systems like SOFA score 
were available only in 481 (83.6%) patients. Among patients whose initial lactate levels 
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were available, 24.5% had values greater than 4.0. In patients with available SOFA 
scores, 18.7% had SOFA score greater than or equal to 11 at the time of presentation. 
23.8% patients had altered mental status, defined as GCS less than or equal to 14 on 
admission. Among the clinical criteria included in the SIRS score, tachycardia with heart 
rate greater than 90 beats/ minute was the most prevalent, present in 99.3% cases, 
followed by tachypnea (more than 20 breaths/ minute) which was present in 90.6% of the 
patients. Hyperthermia (temperature >38 degree F) was present in 14.3% of patients, 
while only 1 patient was hypothermic (temperature < 38 degree F). 55.8% patients were 
hypotensive with systolic blood pressure less than 100mmHg. 
Elevated serum creatinine levels above 1.2mg/dl was present in 46.0% of the study 
population and 33.8% had deranged liver functions (bilirubin greater than 1.2mg/dl). 
44.7% had thrombocytopnenia with platelet levels less than 1.5 lakh/cumm. Patients with 
leucopenia (WBC count <4000 cells/cumm) and leucocytosis (WBC counts >12,000 
cells/cumm or > 10% blasts) were 7.3% and 55.5% respectively.  
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PRIMARY OUTCOME 
CONDITION AT DISCHARGE: 
Majority of patients (68.7%) clinically improved and were stable at the time of discharge. 
In-hospital mortality was 28.8%. 2.5% of patients did not complete the course of 
treatment and were discharged against the medical advice of the treating team. 
SHOCK INDEX AND MORTALITY: 
Clinically significant association (p values <0.001) was identified between shock index at 
presentation and in-hospital mortality in our study. Patients with higher shock index at 
the time of admission (shock index greater than or equal to 1.0), had higher in-hospital 
deaths (37.68%) than patients with shock index less than 1.0 (7.69%), with an absolute 
difference of 29.99%. This effect of shock index on mortality was irrespective of the 
etiology of infection. 90.9% of deaths caused by gram negative bacilli and 85.7% of 
deaths due to gram positive cocci occurred in the group with shock index value greater 
than 1.0. 95.2% of deaths due to salmonella and other bacterial infections were also in the 
group with high shock index. Similarly in deaths due to dengue (100.0%), scrub (90.0%) 
and H1N1 (86.6%), shock index values greater than 1.0 accounted for majority of the 
deaths. 
The results of our study were comparable to the results obtained by Berger et al (31), 
while assessing the usefulness of shock index in the early recognition of sepsis in the 
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emergency department. They found that shock index greater than or equal to 1.0 was 
associated higher mortality rates (23.3% versus 11.7%). 
 
OTHER SCORING SYSTEMS AND MORTALITY: 
In our study, q  SOFA scores greater than or equal to 2 were associated with higher in-
hospital mortality than q SOFA score less than 2 (41.34% versus 10.68%), with an 
absolute difference of 30.66% and statistical significance. Higher q SOFA score at initial 
assessment accounted for 84.9% of all deaths. Freund et al also found in their study that q 
SOFA score greater than or equal to 2 was associated with higher mortality rates (24%  
versus 3% mortality when q SOFA score less than 2) , and that 70.0% of total deaths 
occurred in the cohort of patients with high q SOFA scores. 
Similarly higher SOFA scores at presentation was also associated with higher mortality 
rates, with 26.73% mortality in patients with initial SOFA score less than 11, and 82.25% 
mortality in patients with initial SOFA score greater than or equal to 11. These mortality 
rates were similar to the data published by the European Society of Critical Care 
Medicine (25) , which mentions less than 40.0% mortality in patients with initial SOFA 
scores less than 11 and higher mortality rates in patients with initial SOFA scores more 
than or equal to 11. 
Lactate levels at admission also served as a useful mortality predictor in our study 
population, with 65.24% mortality rate in patients with higher lactate levels (greater than 
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4mmol/L) compared to 23.69% mortality in patients with initial lactate levels less than 
4mmol/L). 
Even though study by also showed significantly higher mortality rates in patients with 
lacate levels greater than 4 mmol/L (28.4% versus 5.8%), the mortality rates were higher 
in our study groups, in both the lactate groups. Trzeciak et al (30) studied serum lactate as 
a predictor of mortality in patients with infection. Mortality rates in the groups with 
serum lactate levels less than 2 and those with lactate between 2.1- 3.9mmol/L were 15% 
and 25% respectively, whereas the group with lactate level greater than 4mmol/L had 
mortality rate of 38%. 
 
SECONDARY OUTCOMES 
ICU REQUIREMENT: 
In this study group, majority of patients (60.1%) did not require ICU admission and were 
managed in ward alone. 37.0% of patients needed either direct ICU admission or shifting 
to ICU within the initial 48 hours, whereas 2.9% of the study population needed ICU care 
after the first 48 hours of admission. 
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SHOCK INDEX AND ICU ADMISSION WITHIN 48 HOURS: 
90.6% of patients requiring ICU admission in the first 48 hours had shock index values 
greater than or equal to 1.0. The need for ICU admission in the groups with higher and 
lower values of shock index were 48.0%  and 11.6% respectively. 
 
OTHER SCORING SYSTEMS IN PREDICTING ICU REQUIREMENT: 
Patients with q SOFA score greater than or equal to 2 had statistically significant higher 
rates of ICU admission than those with q SOFA scores less than 2 (51.9% versus 
15.38%). 
Higher SOFA scores (90.32% with SOFA greater than 11 versus 37.47% in SOFA score 
less than 11) and high lactate levels (69.49% versus 36.08%) were also found to have 
higher rates of ICU admission. 
 
 
INOTROPE REQUIREMENT 
In our study population it was observed that 36.9% required inotropic support during the 
first 48 hours of hospital stay. 
 
89 
 
 
SHOCK INDEX AND INOTROPE SUPPORT IN FIRST 48 HOURS: 
51.47% patients with shock index values greater than or equal to 1.0 required inotropes to 
maintain mean arterial blood pressure during the initial 48 hours, compared with only 
1.77% patients with shock index value of less than 1.0 who required inotropic support. 
Hence higher shock index was identified to have statistically significant association (p 
value <0.001) with inotrope requirement with an absolute difference of 49.70%. 
OTHER SCORING SYSTEMS: 
Higher q SOFA score at presentation predicted a higher rate of inotropic requirement 
(57.77% requiring inotropes in q SOFA greater than 2, and 6.41% requiring vasopressor 
support in the other group with q SOFA less than 2). 
Inotrope requirements were also higher in group with higher SOFA score (88.70% versus 
36.03%) and high lactate levels (74.57% versus 32.50%) at admission. 
 
    3. VENTILATOR ASSISTANCE 
53.0 % patients did not require any form of ventilator assistance .However,19.7 % 
patients 
 required non invasive ventilation (NIV) and 27.3 % required invasive ventilation during 
the  
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initial 48 hours of hospital stay. 
SHOCK INDEX AND VENTILATOR SUPPORT: 
In this study, statistically significant association (p value <0001) was identified between 
shock index value at admission and the need for ventilator support during the first 48 
hours of hospital stay. In the group with shock index less than 1.0, only 19.52% patients 
required some form of ventilator assistance, compared to 58.37% patients with shock 
index value greater than or equal to 1.0 requiring either NIV or invasive ventilator 
support. 
OTHER SCORING SYSTEMS: 
Higher q SOFA scores were also associated with the greater rates of ventilator support. 
26.92% of patients with q SOFA score less than 2 and 60.7% of patients with q SOFA 
score greater than or equal to 2 required some form of ventilator assistance during their 
initial 48 hours of hospital stay. 
In patients with initial SOFA score greater than or equal to 11, 95.16% patients needed 
either NIV or invasive ventilation. However in patients with SOFA score less than 11, 
only 49.64% required support. 
Lactate levels of greater than or equal to 4 was associated a higher need for ventilator 
support than the group with lower lactate levels (82.2% versus 46.83%). This relation 
was also found to be statistically significant with p value less than 0.001. 
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4.DURATION OF HOSPITAL STAY 
The duration of hospital stay was found to have inverse relation to the severity of illness. 
The median duration of hospital stay in group with shock index greater than or equal to 
1.0 was 6 days (inter-quartile range 4-10 days), while group with shock index less than 
1.0 had a median hospital stay of 7 days with the inter-quartile range from 5-10 days. 
Similarly q SOFA score greater than or equal to 2 had a median of 7 days hospital stay( 
inter-quartile range 5-10 days), compared to 6 days of hospitalization in the group with q 
SOFA score less than 2 (inter-quartile range 4-9 days). 
SOFA score greater than or equal to 11 and lactate levels greater than 4 were also 
associated with lesser hospital admission days (3.5 days versus 7 days and 5 days versus 
7 days respectively). 
This is explained by the higher mortality rates and subsequent reduction of the in- 
hospital days among the group with worse severity scores at admission. 
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                                                        LIMITATIONS 
 
This is an observational study. Due to the retrospective nature of study, information 
needed for calculating the vital indices ( shock index, q SOFA, SOFA scores) were 
obtained from hospital records. 
There were no investigations done by the primary investigator. The number of patients 
with confirmed infection could have increased if active investigations like adequate 
cultures and serologies were sent. 
This study was done in a single centre  tertiary care hospital, the disease representation 
may not reflect the actual populations disease spectrum in the community due to referral 
bias.  
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                                                           CONCLUSIONS 
The conclusion of the study are as follows: 
The study described the spectrum of septic patients presenting to a tertiary care hospital 
in south India. 
Gram negative infections still remain the major cause of sepsis, followed by gram 
positive infections and other miscellaneous infections. 
Among the culture negative etiologies, scrub typhus and H1N1 infections were the most 
common. 
Urinary tract and the lungs remain the major site of sepsis. 
Shock index perfomed as a good indicator of in-hospital mortality, and its performance 
was comparable to other established indices like q SOFA scores, SOFA score and lactate 
levels. 
Shock index greater than or equal to 1.0 at initial assessement is associated with greater 
rates of ICU admission, inotropic requirement and ventilator support. 
Usefullness of shock index as a mortality predictor was comparable over all the etiologies 
of sepsis. 
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DIRECTIONS OF FURTHER RESEARCH 
Prospective studies assessing the usefulness of shock index in predicting mortality among 
all patients with suspected or confirmed sepsis. 
Large, multicentre studies to avoid the regional variations in disease frequencies. 
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APPENDIX  I :ACCEPTANCE LETTER BY THE INSTITUTIONAL REVIEW BOARD 
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APPENDIX II:  PERFORMA FOR DATA COLLECTION 
 
STUDY TITLE: Shock index as a predictor of outcome in patients with sepsis. 
 
DEMOGRAPHIC DATA 
Name : 
Hospital number :                                                                   
           Age  :                                                                      
           Gender : 
           
CLINICAL PARAMETERS 
         Heart rate (beats /min): 
         Systolic BP (mmHg): 
         Diastolic BP (mmHg): 
         Mean arterial pressure (mmHg): 
         Respiratory rate (breath/min): 
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         Temperature (degree F): 
         Glasgow coma scale: 
 
LAB PARAMETERS 
          Lactate levels: 
          Arterial pH: 
          Serum HCO3 (mmol/L): 
          P/F ratio: 
          Sodium (meq/L): 
          Potassium (meq/L): 
          Creatinine (mg/dl): 
          Bilirubin (mg/dl): 
          Hemoglobin (gm%): 
          WBC count (per cubic mm): 
          Platelet count (per cubic mm): 
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MICROBIOLOGY 
Blood culture-  positive / negative/not done. 
Urine culture -  positive / negative/not done. 
Sputum culture-  positive / negative/not done. 
CSF culture-  positive / negative/not done. 
Ascitic fluid -  positive / negative/not done. 
Dengue serology- positive / negative/not done. 
Leptospira serology- positive / negative/not done. 
Scrub serology- positive / negative/not done. 
H1N1 PCR- positive / negative/not done. 
Chest Xray- suggestive / not suggestive. 
Identified bacteria:  
 
 
 
COURSE IN HOSPITAL 
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Direct ICU admission (yes/no) 
Ward stay alone (yes/no) 
Transfer to ICU from ward within 48 hours (yes/no) 
Duration of total hospital stay (in days) 
Inotropes requirement – yes/ no 
Ventilatory requirements (invasive/ non invasive)- yes/no. 
 
CONDITION AT DISCHARGE 
1.Improved 
2.Death 
3.Discharge against medical advise. 
 
CALCULATED INDICES 
SOFA score 
qSOFA score 
SHOCK INDEX 
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APPENDIX  III : INRORMATION SHEET 
 
                                INFORMATION SHEET 
INFORMATION SHEET 
Study Title- Shock index as predictor of outcome in paients with septic shock. 
Study title for lay public- The usefulness of shock index in predicting death or survival in 
patients with fever and low blood pressure. 
Purpose- Fever associated with low blood pressure is a leading cause of death. There are 
warning signs like high heart rate and some blood tests which can indicate severity of the 
condition. If these warning signs are identified early, death could be prevented.  
Procedure- blood pressure and heart rate will be recorded. Blood tests necessary to 
identify the cause of fever will be done. 
Benefit to subject- It will be ensured that necessary tests for diagnosis of fever will be 
carried out at the appropriate time. 
Benefit to others- Fever with low blood pressure is a leading cause of death. By 
identifying the risk factors early, adverse outcome ( death ) could be prevented. 
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Confidentiality- Patients personal details will e kept confidential and wil not be revealed 
at any time except by law to share any such information. 
Participation- It is your decision whether to take part in the study or not. There is no 
compulsion. A decision not to take part in the study will not affect the standard of care. 
No money or additional tests have to be done as part of study. 
Results and publication- The results of the study will be analysed and submitted as part of 
my thesis and if approved, will be published for the interest of medical fraternity. 
The results of the study will be published in a medical journal,but you will not be 
identified by name in any publication. 
 
For any further details feel free to contact the principal investigator: 
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APPENDIX  IV : CONSENT FORM 
Study Title: SHOCK INDEX AS PREDICTOR OF OUTCOME IN PATIENTS WITH  
SEPSIS. 
 
Study Number: 
Participant’s name:       CMC Hosp No: 
         
Date of Birth / Age (in years): 
I_____________________________________________________________ 
___________, son/daughter/husband/wife of  ___________________________________ 
(Please tick boxes) 
Declare that I have read the information sheet provided to me regarding this study and 
have clarified any doubts that I had. [ ] 
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I also understand that my participation in this study is entirely voluntary and that I am 
free to withdraw permission to continue to participate at any time without affecting my 
usual treatment or my legal rights. [ ] 
I understand that I will receive free treatment for any study related injury or adverse 
event, but I will not receive any other financial compensation. [ ] 
I understand that the study staff and institutional ethics committee members will not need 
my permission to look at my health records even if I withdraw from the trial.  
I agree to this access. [ ]  
I understand that my identity will not be revealed in any information released to third 
parties or published. [ ]   
I voluntarily agree to take part in this study. [ ] 
Signature (or Thumb impression) of the Subject/ Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
114 
 
Study Investigator’s Name: _________________________ 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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APPENDIX  V – ABSTRACT 
BACKGROUND 
Severe sepsis has substantial clinical and financial, challenges. Previous studies have 
shown that early identification of sepsis is associated with better outcome. However 
limited resources are a major obstacle in early identification of sepsis patients. This is 
also complicated by the various etiologies responsible for sepsis and the heterogenecity 
presentations. Shock index gains significance in this context as it is an easily calculable 
score which can even be measured by non-medical personnel. 
  AIM 
To study the disease spectrum of patients with suspected sepsis and assess the usefulness 
of shock index in predicting the clinical outcome . 
 
 OBJECTIVES 
PRIMARY OBJECTIVE: 
To assess whether in patients with suspected sepsis, shock index  is a good predictor of 
clinical outcome. 
SECONDARY OBJECTIVES: 
Role of shock index in predicting ICU requirement. 
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Shock index in predicting hemodynamic support. 
Shock index in predicting ventilatory requirement. 
Shock index and its relation to duration of hospital stay. 
Correlation of shock index with other mortality predictors (lactate levels, initial SOFA 
score and q SOFA score). 
Usefullness of shock index across the various etiologies for sepsis. 
METHODS 
We conducted a cohort study of patients with suspected and/or confirmed infection 
fulfilling atleast 2 SIRS criteria who presented to the emergency department and were 
subsequently admitted in the medical wards or in the medical ICU. This was a single 
center study done at Christian Medical college , Vellore, a tertiary care hospital primarily 
catering to the middle and low income group patients from all over India, predominantly 
the south Indian and the north eastern states. From the initial emergency department 
documentation of the heart rate and systolic blood pressure, shock index was calculated. 
Similarly SOFA score, q SOFA scores were calculated and the initial lactate levels were 
noted. Usefullness of shock index in predicting the in-hospital mortality was assessed and 
this was compared with other outcome predictors like SOFA score, q SOFA score and 
lactate. 
FINDINGS 
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Between January 1
st
 2016 and June 30
th
 2017, 575 patients fulfilling the inclusion criteria 
were enrolled into the study. Diabetes was identified as a major risk factor, present in 
34.6% of patients. Majority of culture proven infections were caused by gram negative 
bacteria. E.coli was the major gram negative bacteria and staphylococcus aureus was the 
main gram positive bacteria. Urinary tract (24.7%) and lungs (15.8%) were the major 
source of sepsis. Scrub typhus (16.1%) and H1N1 (7.3% ) accounted for majority of 
culture negative infections. 70.6% of the study population had shock index values greater 
than equal to 1.0 at the time of presentation to the emergency department. Patients with 
higher shock index at the time of admission (shock index greater than or equal to 1.0), 
had higher in-hospital deaths (37.68%) than patients with shock index less than 1.0 
(7.69%), with an absolute difference of 29.99% and p value less than 0.001. This effect of 
shock index on mortality was irrespective of the etiology of infection. Similarly shock 
index values greater than 1.0 was also associated with higher rates of ICU admission 
(48.0% versus 11.6%) , greater need of inotropic (51.47% versus 1.77%) and ventilator 
support (58.37% versus 19.52%) during the initial 48 hours of hospital stay. Performance 
of shock index was comparable with that of SOFA, q SOFA and lactate. 
CONCLUSION 
Higher shock index (greater than 1.0) values at the time of presentation was associated 
with higher mortality rates, higher rates of ICU admission and greater need for ventilator 
and inotropic support. Hence it can be used as a triaging tool for septic patients, 
especially in the resource poor settings. 
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